Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ABC
ABcann Global
C$0.00
C$0.00
C$0.00
N/AN/AN/AN/A
Abcam plc stock logo
ABCM
Abcam
$23.99
$23.88
$12.48
$25.32
$5.50B0.863.08 million shs3,300 shs
Cronos Group Inc. stock logo
CRON
Cronos Group
$2.07
-1.0%
$1.98
$1.60
$2.54
$798.36M1.031.65 million shs1.94 million shs
Genius Group Limited stock logo
GNS
Genius Group
$1.57
-0.6%
$0.63
$0.21
$3.20
$137.86M10.985.33 million shs3.82 million shs
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
$4.22
+1.0%
$2.52
$1.26
$7.40
$951.51M1.865.97 million shs5.83 million shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abcam plc stock logo
ABCM
Abcam
0.00%0.00%0.00%0.00%0.00%
Cronos Group Inc. stock logo
CRON
Cronos Group
0.00%+2.45%+8.29%+21.51%-13.28%
Genius Group Limited stock logo
GNS
Genius Group
0.00%+9.72%+311.46%+519.12%-36.39%
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
0.00%+30.83%+61.39%+130.94%-29.75%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ABC
ABcann Global
N/AN/AN/AN/AN/AN/AN/AN/A
Abcam plc stock logo
ABCM
Abcam
N/AN/AN/AN/AN/AN/AN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
1.5862 of 5 stars
0.04.00.00.01.50.02.5
Genius Group Limited stock logo
GNS
Genius Group
0.7567 of 5 stars
0.02.00.00.02.91.70.6
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
3.2737 of 5 stars
3.53.00.00.02.73.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ABC
ABcann Global
0.00
N/AN/AN/A
Abcam plc stock logo
ABCM
Abcam
0.00
N/AN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
0.00
N/AN/AN/A
Genius Group Limited stock logo
GNS
Genius Group
0.00
N/AN/AN/A
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
3.00
Buy$9.17117.22% Upside

Current Analyst Ratings Breakdown

Latest ABCM, SANA, CRON, GNS, and ABC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/3/2025
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$12.00
6/24/2025
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$5.00
4/24/2025
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00 ➝ $11.00
(Data available from 7/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ABC
ABcann Global
N/AN/AN/AN/AN/AN/A
Abcam plc stock logo
ABCM
Abcam
$379.70M14.49$0.60 per share40.17$3.92 per share6.12
Cronos Group Inc. stock logo
CRON
Cronos Group
$117.61M6.79N/AN/A$2.90 per share0.71
Genius Group Limited stock logo
GNS
Genius Group
$7.91M17.43N/AN/A$1.23 per share1.28
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
N/AN/AN/AN/A$1.12 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ABC
ABcann Global
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Abcam plc stock logo
ABCM
Abcam
-$10.51MN/A0.0042.092.19N/AN/AN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
$41.08M$0.1315.9269.00N/A39.69%-0.07%-0.07%8/6/2025 (Estimated)
Genius Group Limited stock logo
GNS
Genius Group
-$24.88MN/A0.00N/AN/AN/AN/AN/A7/30/2025 (Estimated)
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
-$266.76M-$0.88N/AN/AN/AN/A-86.58%-44.49%8/6/2025 (Estimated)

Latest ABCM, SANA, CRON, GNS, and ABC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Cronos Group Inc. stock logo
CRON
Cronos Group
$0.01$0.02+$0.01$0.02$45.44 million$33.62 million
5/8/2025Q1 2025
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
-$0.22-$0.20+$0.02-$0.21N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ABC
ABcann Global
N/AN/AN/AN/AN/A
Abcam plc stock logo
ABCM
Abcam
N/AN/AN/AN/AN/A
Cronos Group Inc. stock logo
CRON
Cronos Group
N/AN/AN/AN/AN/A
Genius Group Limited stock logo
GNS
Genius Group
N/AN/AN/AN/AN/A
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ABC
ABcann Global
N/AN/AN/A
Abcam plc stock logo
ABCM
Abcam
N/A
1.35
1.00
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A
27.80
26.75
Genius Group Limited stock logo
GNS
Genius Group
0.13
3.65
3.61
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
N/A
3.40
3.40

Institutional Ownership

CompanyInstitutional Ownership
ABC
ABcann Global
N/A
Abcam plc stock logo
ABCM
Abcam
90.45%
Cronos Group Inc. stock logo
CRON
Cronos Group
8.71%
Genius Group Limited stock logo
GNS
Genius Group
14.28%
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
88.23%

Insider Ownership

CompanyInsider Ownership
ABC
ABcann Global
N/A
Abcam plc stock logo
ABCM
Abcam
6.73%
Cronos Group Inc. stock logo
CRON
Cronos Group
6.90%
Genius Group Limited stock logo
GNS
Genius Group
51.19%
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
30.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
ABC
ABcann Global
N/AN/AN/ANot Optionable
Abcam plc stock logo
ABCM
Abcam
1,760229.27 million213.84 millionOptionable
Cronos Group Inc. stock logo
CRON
Cronos Group
450385.68 million359.07 millionOptionable
Genius Group Limited stock logo
GNS
Genius Group
48087.81 million42.86 millionNot Optionable
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
380225.48 million155.35 millionOptionable

Recent News About These Companies

Sana Biotechnology (NASDAQ:SANA) Now Covered by Morgan Stanley
Sana Biotechnology (SANA) Receives a Buy from Citizens JMP
BofA Remains Bullish on Sana Biotechnology (SANA)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abcam stock logo

Abcam NASDAQ:ABCM

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Cronos Group stock logo

Cronos Group NASDAQ:CRON

$2.07 -0.02 (-0.96%)
Closing price 04:00 PM Eastern
Extended Trading
$2.09 +0.02 (+0.97%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Genius Group stock logo

Genius Group NYSEAMERICAN:GNS

$1.57 -0.01 (-0.63%)
Closing price 04:10 PM Eastern
Extended Trading
$1.58 +0.01 (+0.96%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Genius Group Limited, through its subsidiaries, provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company operates through two segments, Education and Campus. It develops comprehensive entrepreneurial education curriculum with a full suite of tools for student learning and faculty earning. The company also owns entrepreneur resorts in Bali and South Africa, which run entrepreneur retreats and workshops; and Genius Café, an entrepreneur beach club in Bali, as well as Genius Central, an entrepreneur co-working hub in Singapore. In addition, it offers home childcare and investment education services; operates entrepreneur education campus that provides a range of programs from pre-primary through primary school, secondary school, and vocational college; and provides career-focused on-campus and online programs at the master's, bachelor's and associate degree level, as well as certificate and continuing education programs. The company operates in Europe/the Middle East/Africa, the Asia/Pacific, and North America/South America. Genius Group Limited was founded in 2002 and is headquartered in Singapore.

Sana Biotechnology stock logo

Sana Biotechnology NASDAQ:SANA

$4.22 +0.04 (+0.96%)
Closing price 04:00 PM Eastern
Extended Trading
$4.24 +0.02 (+0.36%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, B-cell-mediated autoimmune, and others. The company's product candidates include SC291 that is used as allogeneic cell therapies for hematologic malignancies; ARDENT for a potential treatment for non-Hodgkin's lymphoma, and chronic lymphoblastic leukemia; GLEAM, to treat multiple autoimmune disorders that involve production of autoimmune antibodies, including lupus nephritis, extrarenal lupus, antineutrophil cytoplasmic antibody -associated vasculitis, and others. It is developing SC262 to treat patients with relapsed and/or refractory B-cell malignancies; SC255 for multiple myeloma treatment; SC379, a therapy for patients with certain central nervous system disorders healthy allogeneic glial progenitor cells; SC451, a product candidate to treat diabetes, with an initial focus on type 1 diabetes mellitus; and UP421 that reduces long-term exogenous insulin dependence. The company has an option and license agreement with Beam Therapeutics Inc. for use of Beam's proprietary CRISPR Cas12b nuclease editing technology to research, develop, and commercialize engineered cell therapy products; and a license agreement with Harvard College to access certain intellectual property for the development of hypoimmune-modified cells. The company was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. Sana Biotechnology, Inc. was incorporated in 2018 and is headquartered in Seattle, Washington.